And when Fauci was telling the White House Coronavirus Task Force that there was only anecdotal evidence in support of hydroxychloroquine to fight the virus, I confronted him with scientific studies providing evidence of safety and efficacy. A recent Detroit hospital study showed a 50% reduction in the mortality rate when the medicine is used in early treatment.
Peter Navarro, an assistant to the president, is the director of the Office of Trade and Manufacturing Policy